Cargando…

Ten‐Year Simulation of the Effects of Denosumab on Bone Remodeling in Human Biopsies

Postmenopausal osteoporosis is a disease manifesting in degradation of bone mass and microarchitecture, leading to weakening and increased risk of fracture. Clinical trials are an essential tool for evaluating new treatments and may provide further mechanistic understanding of their effects in vivo....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tourolle, Duncan C, Dempster, David W, Ledoux, Charles, Boaretti, Daniele, Aguilera, Mauricio, Saleem, Najma, Müller, Ralph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216138/ https://www.ncbi.nlm.nih.gov/pubmed/34189383 http://dx.doi.org/10.1002/jbm4.10494

Ejemplares similares

Clinical Data for Parametrization of In Silico Bone Models Incorporating Cell-Cytokine Dynamics: A Systematic Review of Literature
por: Ledoux, Charles, et al.
Publicado: (2022)

Trabecular bone remodeling in the aging mouse: A micro-multiphysics agent-based in silico model using single-cell mechanomics
por: Boaretti, Daniele, et al.
Publicado: (2023)

Individualized cyclic mechanical loading improves callus properties during the remodelling phase of fracture healing in mice as assessed from time-lapsed in vivo imaging
por: Wehrle, Esther, et al.
Publicado: (2021)

Modeling‐Based Bone Formation in the Human Femoral Neck in Subjects Treated With Denosumab
por: Dempster, David W, et al.
Publicado: (2020)

Tissue-Level Regeneration and Remodeling Dynamics are Driven by Mechanical Stimuli in the Microenvironment in a Post-Bridging Loaded Femur Defect Healing Model in Mice
por: Paul, Graeme R., et al.
Publicado: (2022)

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
por: Dempster, David W, et al.
Publicado: (2018)

Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
por: Martínez-Reina, Javier, et al.
Publicado: (2021)

Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial
por: Chavassieux, Pascale, et al.
Publicado: (2019)

Real-time finite element analysis allows homogenization of tissue scale strains and reduces variance in a mouse defect healing model
por: Paul, Graeme R., et al.
Publicado: (2021)

Mechanostat parameters estimated from time-lapsed in vivo micro-computed tomography data of mechanically driven bone adaptation are logarithmically dependent on loading frequency
por: Marques, Francisco C., et al.
Publicado: (2023)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman, Ursa, et al.
Publicado: (2013)

Effect of risedronate on bone loss at discontinuation of denosumab
por: Laroche, Michel, et al.
Publicado: (2020)

Bone Health and Denosumab Discontinuation in Oncology Populations
por: Cheung, Yee-Ming Melody, et al.
Publicado: (2022)

The Effect of Denosumab on Bone Mass in Super Elderly Patients
por: Jeong, Chaiho, et al.
Publicado: (2020)

Amelioration of Paget Disease of Bone After Denosumab for Osteopenia
por: Kamalumpundi, Vijayvardhan, et al.
Publicado: (2023)

Evaluation of longitudinal time-lapsed in vivo micro-CT for monitoring fracture healing in mouse femur defect models
por: Wehrle, Esther, et al.
Publicado: (2019)

Clinical utility of denosumab for treatment of bone loss in men and women
por: Adler, Robert A, et al.
Publicado: (2011)

Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller, Channing J, et al.
Publicado: (2012)

Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh, Arun S, et al.
Publicado: (2015)

'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015)

A Recurrent Giant Cell Tumor of Bone Treated with Denosumab
por: Stadler, Nicola, et al.
Publicado: (2015)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
por: Egbert, Ryan Carlisle, et al.
Publicado: (2017)

Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
por: Otani, Shinya, et al.
Publicado: (2019)

Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
por: Li, Hengyuan, et al.
Publicado: (2020)

Radiological findings of denosumab treatment for giant cell tumours of bone
por: van Langevelde, Kirsten, et al.
Publicado: (2020)

Bone Mineral Density After Transitioning From Denosumab to Alendronate
por: Kendler, David, et al.
Publicado: (2019)

Aneurysmal bone cyst: results of an off label treatment with Denosumab
por: Dürr, Hans Roland, et al.
Publicado: (2019)

Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
por: Müller, Daniel A., et al.
Publicado: (2016)

The association between mineralised tissue formation and the mechanical local in vivo environment: Time-lapsed quantification of a mouse defect healing model
por: Tourolle né Betts, Duncan C., et al.
Publicado: (2020)

Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
por: Sawamura, Masato, et al.
Publicado: (2017)

Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
por: Hakozaki, Michiyuki, et al.
Publicado: (2014)

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab
por: Mukaihara, Kenta, et al.
Publicado: (2016)

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone
por: Borkowska, Aneta, et al.
Publicado: (2016)

Recurrent Aneurysmal Bone Cyst of the Distal Fibula Treated with Denosumab and Curettage
por: Fontenot, Philip B., et al.
Publicado: (2018)

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
por: Upfill‐Brown, Alexander, et al.
Publicado: (2019)

Aggressive osteoblastoma with a secondary aneurysmal bone cyst treated with denosumab
por: Wong, Karlton, et al.
Publicado: (2021)

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
por: Park, Jung-Wee
Publicado: (2021)

The Effect of Denosumab in Elderly Patients Regarding Bone Density and Fracture Risk
por: Yoon, Sung-Hyun, et al.
Publicado: (2023)

OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023)

Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hd1oav72a8tdc865p938acrvt4